华东医药：2021年半年度报告（英文版）.PDF

1、The Half Year Report 2021 of Huadong Medicine Co.,Ltd 1 Huadong Medicine Co.,Ltd.The Half Year Report 2021 August 2021 The Half Year Report 2021 of Huadong Medicine Co.,Ltd 2 Section I.Important Declaration,Contents and Definitions The Board of Directors,Board of Supervisors,directors,supervisors an

2、d senior management of Huadong Medicine Co.,Ltd.(hereinafter referred to as the“Company”)hereby guarantee that the information presented in this half year report is authentic,accurate and complete and free of any false records,misleading statements or material omissions,and shall undertake individua

3、l and joint legal liabilities.Lv Liang,the Companys legal representative and the officer in charge of accounting,and Qiu Renbo,head of accounting department(accounting supervisor)hereby declare and guarantee that the financial statements in this half year report are authentic,accurate and complete.A

4、ll directors have attended the Board of Directors meeting to review this half year report.The future plans,development strategies and other forward-looking statements in this half year report shall not be considered as substantial commitment of the Company to investor.Investors and related parties s

5、hould maintain sufficient risk awareness,and should understand the difference between plans,forecasts and promises.Investors are kindly reminded to pay attention to possible investment risks.The Company faced various risks in its operations,involving industry The Half Year Report 2021 of Huadong Med

6、icine Co.,Ltd 3 policies,markets,R&D of new drugs,product price reduction,etc.For details,refer to“X.Risks and Countermeasures”in“Section III.Discussion and Analysis of the Management”.We thank all investors for paying attention to the Companys operations,and we hope that you can be aware of investm